Hyderabad: Even as Lancet published the results of Phase-1 and Phase-2 clinical trial data of the Sputnik V vaccine — cleared by Moscow regulators for public use — the Russian research institute has now submitted "comprehensive data" on the vaccine’s safety and efficacy to Indian authorities.
Senior officials said that India had sought this from the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology. The vaccine candidate triggered a "strong" immune response in Phases 1 & 2 of the clinical trials on 76 people.
As this "comprehensive data" is evaluated by experts in India, one option, sources said, is to have a separate Phase 3 clinical trial after necessary approvals from regulators. The production of the vaccine is expected to start in September 2020.
Chhattisgarh
Raipur: Chief Minister Bhupesh Baghel held a discussion in detail with his cabinet ministers, District Collectors, Superintendent of Police (SPs) and Medical Officials via video conferencing about the status of corona infection in Chhattisgarh.
Baghel in his address to the ministers and officials said that increasing number of COVID positive cases has created an environment of fear among common people, especially the patients.
He directed the officials concerned to monitor the health conditions of patients and to ensure regular visits of doctors in their wards. He said that the patients should be provided necessary medical advice via telemedicine or video or WhatsApp calling as well.
The Chief Minister also said that the decision to prescribe treatment in home isolation to the patients with few or no symptoms will reduce the pressure on hospitals.
Jharkhand
Ranchi: Jharkhand's COVID-19 tally crossed 50,000-mark with the detection of 1,246 new cases, while seven fresh fatalities pushed the state's coronavirus death toll to 469, a health bulletin said. The fresh infections have taken the state's caseload to 51,063, whereas the recovery rate in the state stands at 71.86 per cent, it said.